GYEMSZI - MOB

ELďż˝ADďż˝S - Kapcsolódó tételek

51.			Drug Development Strategy in the United States: An Industrial View of DMPK
52.			Drugs are Absorbed in Finite Time: A New Era in Biopharmaceutics and Pharmacokinetics
53.			Effect Of Graphene Oxide Nanoparticles on the Performance of Aerobic Granular Sludge Treatment System
54.			Effect of Molar Mass of Hydroxypropyl ß-cyclodextrin on the Aqueous Solubility of Dimenhydrinate
55.			Egészség- és betegségnarratívák a mesében
56.			Az Elektronikus Egészségügyi Szolgáltatási Tér szakmapolitikai nézőpontból: kihívás és lehetőség
57.			Az elhízással kapcsolatos krónikus betegségek mozgásterápiaá kezelésének lehetőségei
58.			EMA's proposed Guideline on Quality and Equivalence of Topical Products and Nanotechnology: Future Advances and Challenges
59.			Enantioselective Separations Based on High-performance Liquid Chromatography
60.			Ensuring Patient Safety through Regulatory Clarity
61.			EPIPHARMA - From Cutting Edge Synthesis Technologies to Complete Preclinical Characterization
62.			Estimating the Toxic Potential of Entactogens - In silico Study
63.			Ethanol Based Formulations and the Solubility-Permeability Interplay; does Ethanol Increase the Intestinal Permeability?
64.			Evaluation of a Pneumatic Tube System for Delivering Nivolumab Diluted Solutions
65.			Evaluation of Different Pre-Processed Directly Compressible Paracetamol
66.			Evolution of Biosimilar Medicines on the Romanian Pharmaceutical Market
67.			Factors associated with postural control in nursing home residents : Oral presentation at the 13th Conference of the Hungarian Medical Association of America ? Hungary Chapter (HMAA-HC) at 30?31 Au...
68.			Flowability of Pharmaceutical Powders: Impact of Humidity
69.			Formulation and Complex Morphological Characterization of Core-Shell Fibrous Mats for Chronic Wound Healing
70.			Formulation and Investigation of Gels Containing Spirulina Powder
71.			Formulation and Physiochemical Characterization of NLC-miRNA Complexes
72.			Formulation of Apigenin-Loaded Liposomes for Pulmonary Delivery
73.			Formulation of Baicalin-loaded Self-nanoemulsifying Matrix Pellets
74.			Future of the Hungarian Drug Market - Role of the Hungarian Regulatory Authority
75.			GGlobal Biosimilar Drug Development: Any Chance for Consolidation after 15 Years of Positive Regulatory Experience?
76.			Glycopeptide Antibiotic Derivatives Against Resistant Bacteria
77.			The Gut in a Beaker: More Challenges for In Vitro Testing
78.			Gyermekkori pszichés zavarok kutatócsoport friss eredményeinek bemutatása
79.			Gyógyszer-indukált alvásendoszkópia (DISE)
80.			Ha az Instagram tükre bennünk görbül: a közösségi média és a testkép összefüggései
81.			Hagyományos és PCR alapú biodozimetriai módszerek a katasztrófavédelemben
82.			Havi egy millió - van amikor sok, van amikor kevés
83.			High-Through put Screening for Bioactive Natural Compounds from Plant Extracts by HPTLC Hyphenations
84.			A HILIC-MS/MS Method for the Structural Analysis of Human Alpha-1-Acid Glycoprotein
85.			History of cataract surgery from ancient times to today : Oral presentation at the 13th Conference of the Hungarian Medical Association of America ? Hungary Chapter (HMAA-HC) at 30?31 August 2019, ...
86.			A Honvéd Testalkati Programban résztvevők testösszetétel változása 6 hónapos diétás és mozgásprogram hatására
87.			How Should Synthetic Follow-Ons of Biological Products Be Regulated? What Are the Implications for Automatic?
88.			How to Deal with Complexity of Nanomedicine in Practice
89.			Hydrocolloid Gel-Formers and Polyvalent Cations in the Formation of Microparticles
90.			Image Analysis: A Novel Method in the Assessment of Pharmaceutical Foams
91.			Impact of one High Dose of Ceftazidime Administrated before Minimally Invasive Multimodal Endoscopic Prostate Surgery
92.			ImpulzÍV - a kutatásoktól a klinikumig és vissza: az impulzivitás megjelenési formáinak mérési lehetőségei pszichés zavarokban
93.			Industry Perspectives in Modern Drug Research and Development Strategies
94.			Insights for a Risk-Assessment Tool to Manage Medicines Shortages
95.			Interfacial Properties of Biodegradable Drug Carrier Nanoparticles
96.			Investigating the Influence of Heat Stress to the Activity And Structural Changes of Lactase Enzyme
97.			Investigation of the Drug Dose, Alongside the Solubility, the Permeability, and their Interplay, as Key Factors in Formulation Development for Oral Lipophilic Drugs
98.			Is the Multi-Attribute Method (MAM) the Next Big Thing? : A High-Resolution Accurate Mass Multi-Attribute Method for Critical Quality Attribute Monitoring
99.			Isolation and Analysis of Human Urinary Marker Protein uAGP by Liquid Chromatographic Methods
100.			A kockázatos alkoholfogyasztás és a visszaélésszerű gyógyszerhasználat összefüggésének vizsgálata hazai reprezentatív mintán

Mind kijelölve: